\begin{table}[p]
	\centering
	\caption{The relationship between clinico-pathological characteristics and survival in patients undergoing pancreatic resections for pancreatic ductal adenocarcinoma (n=47): Cox regression analysis}
	\label{table:cpet_survival_cox}
	%\renewcommand{\arraystretch}{1.2} %Increases space between rows
	%\setlength{\tabcolsep}{9pt} %sets the space between columns
	\begin{tabular}{C{5mm} l c c c c c c c}
		\multicolumn{2}{l}{Variable}     & n            & HR   & 95\% CI     & P     & HR    & 95\% CI     & p     \\ \hline
		\multicolumn{9}{l}{Age (years)}                                                                            \\
		 & $\leq$ 65 / $>$ 65            & 22 / 25      & 1.19 & 0.61-2.32   & 0.621 &       &             &  \\
		\multicolumn{9}{l}{Sex}                                                                                    \\
		 & Male / Female                 & 31 / 16      & 0.58 & 0.28-1.21   & 0.146 &       &             &  \\
		\multicolumn{9}{l}{BMI (kg/sq.m)}                                                                          \\
		 & $\leq$ 25 / $>$ 25            & 22 / 25      & 1.07 & 0.55-2.08   & 0.853 &       &             &  \\
		\multicolumn{9}{l}{Smoking}                                                                                \\
		 & No / Yes                      & 27 / 19      & 1.23 & 0.63-2.43   & 0.544 &       &             &  \\
		\multicolumn{9}{l}{POSSUM Physiology Score}                                                                \\
		 & $\leq$ 14 / $>$ 14            & 26 / 21      & 2.35 & 1.18 - 4.69 & 0.015 & 2.375 & 1.19 - 4.75 & 0.014 \\
		\multicolumn{9}{l}{Preoperative Biliary Drainage}                                                          \\
		 & No / Yes                      & 14 / 25      & 0.92 & 0.44-1.93   & 0.832 &       &             &  \\
		\multicolumn{9}{l}{Serum Bilirubin (micromol/L)}                                                           \\
		 & $\leq$ 35 /35 - 250 / $>$ 250 & 24 / 13 / 10 & 0.13 & 0.83-4.29   & 0.132 &       &             &  \\
		\multicolumn{9}{l}{mGPS}                                                                                   \\
		 & 0 / 1 / 2                     & 33 / 1 / 13  & 2.13 & 1.01-4.48   & 0.046 &       &             &  \\
		\multicolumn{9}{l}{C-Reactive Protein (mg/dl)}                                                             \\
		 & $\leq$ 10 / $>$ 10            & 33 / 14      & 2.14 & 1.04-4.41   & 0.040 &       &             & 0.436 \\
		\multicolumn{9}{l}{Serum Albumin (g/dl)}                                                                   \\
		 & $\geq$ 35 / $<$ 35            & 18 / 29      & 1.67 & 0.82-3.41   & 0.157 &       &             &  \\
		\multicolumn{9}{l}{Haemoglobin (g/dl)}                                                                     \\
		 & $\geq$ 12  / $<$ 12           & 35 / 12      & 1.68 & 0.80-3.52   & 0.174 &       &             &  \\
		\multicolumn{9}{l}{$\dot{V}_{O_2}$AT (ml/kg/min)}                                                          \\
		 & $\geq$ 10 / $<$ 10            & 23 / 24      & 1.34 & 0.69-2.63   & 0.392 &       &             &  \\
		\multicolumn{9}{l}{$\dot{V}_{O_2}$Peak (ml/kg/min)}                                                        \\
		 & $\geq$ 15 / $<$ 15            & 22 / 25      & 1.06 & 0.54-2.06   & 0.865 &       &             &  \\
		\multicolumn{9}{l}{$\dot{V}_E/\dot{V}_{CO_2}$}                                                             \\
		 & $\leq$ 34 / $>$ 34            & 23 / 23      & 1.35 & 0.69-2.64   & 0.382 &       &             &  \\ \hline
	\end{tabular}
\end{table}